Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
535.25
-0.02 (0.00%)
Aug 12, 2026, 10:07 AM EDT - Market open

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $364.25M in the quarter ending June 30, 2026, with 71.17% growth. This brings the company's revenue in the last twelve months to $1.28B, up 149.04% year-over-year. In the year 2025, Madrigal Pharmaceuticals had annual revenue of $958.40M with 432.05% growth.

Revenue (ttm)
$1.28B
Revenue Growth
+149.04%
P/S Ratio
9.60
Revenue / Employee
$1,403,213
Employees
915
Market Cap
12.37B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025958.40M778.27M432.05%
Dec 31, 2024180.13M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012147.00K-7.44M-98.06%
Dec 31, 20117.58M-7.22M-48.77%
Dec 31, 201014.80M-129.44M-89.74%
Dec 31, 2009144.25M141.63M5,416.06%
Dec 31, 20082.62M1.87M251.95%
Dec 31, 2007743.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BioMarin Pharmaceutical3.41B
Exelixis2.44B
Halozyme Therapeutics1.66B
Bio-Techne1.21B
Corcept Therapeutics830.81M
Axsome Therapeutics708.24M
Arrowhead Pharmaceuticals669.50M
Cytokinetics67.67M
Revenue Rankings

MDGL News

More News